$BSTG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Biostage, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Biostage, Inc.. Get notifications about new insider transactions in Biostage, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 01 2021 | BSTG | Biostage, Inc. | Sanchez Herman | Director | Option Exercise | A | 1.80 | 16,413 | 29,543 | 16,413 | |
Feb 01 2021 | BSTG | Biostage, Inc. | Sanchez Herman | Director | Option Exercise | A | 1.80 | 16,413 | 29,543 | 16,413 | |
Sep 15 2020 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Option Exercise | J | 2.00 | 100,000 | 200,000 | 7,000 | |
Sep 15 2020 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Option Exercise | J | 2.00 | 100,000 | 200,000 | 107,000 | |
Sep 15 2020 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Option Exercise | J | 2.00 | 100,000 | 200,000 | 207,000 | |
Sep 15 2020 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Option Exercise | J | 2.00 | 51,500 | 103,000 | 307,000 | |
Jun 29 2020 | BSTG | Biostage, Inc. | Young Jeffrey E | Director | Option Exercise | A | 2.52 | 9,579 | 24,139 | 21,517 | |
Jun 29 2020 | BSTG | Biostage, Inc. | Young Jeffrey E | Director | Option Exercise | A | 2.52 | 11,938 | 30,084 | 11,938 | |
Jun 29 2020 | BSTG | Biostage, Inc. | Li Ting | Director | Option Exercise | A | 2.52 | 9,579 | 24,139 | 21,517 | |
Jun 29 2020 | BSTG | Biostage, Inc. | Li Ting | Director | Option Exercise | A | 2.52 | 11,938 | 30,084 | 11,938 | |
Jun 29 2020 | BSTG | Biostage, Inc. | Zhang Wei | Director | Option Exercise | A | 2.52 | 9,579 | 24,139 | 21,517 | |
Jun 29 2020 | BSTG | Biostage, Inc. | Zhang Wei | Director | Option Exercise | A | 2.52 | 11,938 | 30,084 | 11,938 | |
Jun 29 2020 | BSTG | Biostage, Inc. | Shmerling James E. | Director | Option Exercise | A | 2.52 | 9,579 | 24,139 | 21,517 | |
Jun 29 2020 | BSTG | Biostage, Inc. | Shmerling James E. | Director | Option Exercise | A | 2.52 | 11,938 | 30,084 | 11,938 | |
Apr 29 2020 | BSTG | Biostage, Inc. | CHAKOUTIS PETER M | Vice President of F ... | Payment of Exercise | F | 3.05 | 3,157 | 9,629 | 16,638 | 19.8 K to 16.6 K (-15.95 %) |
Apr 29 2020 | BSTG | Biostage, Inc. | CHAKOUTIS PETER M | Vice President of F ... | Payment of Exercise | F | 3.05 | 3,157 | 9,629 | 16,638 | 19.8 K to 16.6 K (-15.95 %) |
Apr 29 2020 | BSTG | Biostage, Inc. | CHAKOUTIS PETER M | Vice President of F ... | Grant | A | 0.00 | 10,000 | 0 | 19,795 | 9.8 K to 19.8 K (+102.09 %) |
Apr 29 2020 | BSTG | Biostage, Inc. | CHAKOUTIS PETER M | Vice President of F ... | Grant | A | 0.00 | 10,000 | 0 | 19,795 | 9.8 K to 19.8 K (+102.09 %) |
Apr 02 2020 | BSTG | Biostage, Inc. | CHAKOUTIS PETER M | Vice President of F ... | Payment of Exercise | F | 4.00 | 5,205 | 20,820 | 9,795 | 15 K to 9.8 K (-34.70 %) |
Apr 02 2020 | BSTG | Biostage, Inc. | CHAKOUTIS PETER M | Vice President of F ... | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Mar 26 2020 | BSTG | Biostage, Inc. | CHAKOUTIS PETER M | Vice President of F ... | Option Exercise | A | 4.00 | 40,000 | 160,000 | 40,000 | |
Feb 06 2020 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Option Exercise | J | 2.00 | 62,500 | 125,000 | 358,500 | |
Feb 06 2020 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Option Exercise | J | 2.00 | 94,000 | 188,000 | 421,000 | |
Dec 06 2019 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Option Exercise | J | 2.00 | 200,000 | 400,000 | 515,000 | |
Oct 02 2019 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Option Exercise | J | 2.00 | 30,000 | 60,000 | 715,000 | |
Oct 02 2019 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Option Exercise | J | 2.00 | 30,000 | 60,000 | 715,000 | |
Oct 02 2019 | BSTG | Biostage, Inc. | Young Jeffrey E | Director | Option Exercise | X | 2.00 | 25,000 | 50,000 | 0 | |
Oct 02 2019 | BSTG | Biostage, Inc. | Young Jeffrey E | Director | Option Exercise | J | 2.00 | 25,000 | 50,000 | 25,000 | |
Oct 02 2019 | BSTG | Biostage, Inc. | Young Jeffrey E | Director | Buy | X | 2.00 | 25,000 | 50,000 | 25,000 | 0 to 25 K |
Sep 04 2019 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Option Exercise | J | 2.00 | 40,000 | 80,000 | 745,000 | |
Sep 04 2019 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Option Exercise | J | 2.00 | 555,000 | 1,110,000 | 785,000 | |
Jun 18 2019 | BSTG | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Option Exercise | A | 2.55 | 35,000 | 89,250 | 35,000 | |
Jun 05 2019 | BSTG | Biostage, Inc. | Shmerling James E. | Director | Option Exercise | A | 2.90 | 8,411 | 24,392 | 18,775 | |
Jun 05 2019 | BSTG | Biostage, Inc. | Shmerling James E. | Director | Option Exercise | A | 2.90 | 10,364 | 30,056 | 10,364 | |
Jun 05 2019 | BSTG | Biostage, Inc. | Young Jeffrey E | Director | Option Exercise | A | 2.90 | 8,411 | 24,392 | 18,775 | |
Jun 05 2019 | BSTG | Biostage, Inc. | Young Jeffrey E | Director | Option Exercise | A | 2.90 | 10,364 | 30,056 | 10,364 | |
Jun 05 2019 | BSTG | Biostage, Inc. | Dallas Matthew D | Director | Option Exercise | A | 2.90 | 8,411 | 24,392 | 18,775 | |
Jun 05 2019 | BSTG | Biostage, Inc. | Dallas Matthew D | Director | Option Exercise | A | 2.90 | 10,364 | 30,056 | 10,364 | |
Jun 05 2019 | BSTG | Biostage, Inc. | Li Ting | Director | Option Exercise | A | 2.90 | 1,270 | 3,683 | 20,045 | |
Jun 05 2019 | BSTG | Biostage, Inc. | Li Ting | Director | Option Exercise | A | 2.90 | 8,411 | 24,392 | 18,775 | |
Jun 05 2019 | BSTG | Biostage, Inc. | Li Ting | Director | Option Exercise | A | 2.90 | 10,364 | 30,056 | 10,364 | |
Jun 05 2019 | BSTG | Biostage, Inc. | Zhang Wei | Director | Option Exercise | A | 2.90 | 5,128 | 14,871 | 23,903 | |
Jun 05 2019 | BSTG | Biostage, Inc. | Zhang Wei | Director | Option Exercise | A | 2.90 | 8,411 | 24,392 | 18,775 | |
Jun 05 2019 | BSTG | Biostage, Inc. | Zhang Wei | Director | Option Exercise | A | 2.90 | 10,364 | 30,056 | 10,364 | |
Jun 05 2019 | BSTG | Biostage, Inc. | Chen Jing | Director | Option Exercise | A | 2.90 | 7,554 | 21,907 | 26,329 | |
Jun 05 2019 | BSTG | Biostage, Inc. | Chen Jing | Director | Option Exercise | A | 2.90 | 8,411 | 24,392 | 18,775 | |
Jun 05 2019 | BSTG | Biostage, Inc. | Chen Jing | Director | Option Exercise | A | 2.90 | 10,364 | 30,056 | 10,364 | |
May 13 2019 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Option Exercise | X | 2.00 | 250,000 | 500,000 | 1,340,000 | |
May 13 2019 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Option Exercise | X | 2.00 | 250,000 | 500,000 | 1,590,000 | |
May 13 2019 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Buy | X | 2.00 | 250,000 | 500,000 | 3,000,000 | 2.8 M to 3 M (+9.09 %) |
May 13 2019 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Buy | X | 2.00 | 250,000 | 500,000 | 2,750,000 | 2.5 M to 2.8 M (+10.00 %) |
Feb 20 2019 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Option Exercise | X | 2.00 | 500,000 | 1,000,000 | 1,840,000 | |
Feb 20 2019 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Buy | X | 2.00 | 500,000 | 1,000,000 | 2,500,000 | 2 M to 2.5 M (+25.00 %) |
Nov 21 2018 | BSTG | Biostage, Inc. | Li Ting | Director | Option Exercise | A | 2.75 | 10,897 | 29,967 | 10,897 | |
Nov 21 2018 | BSTG | Biostage, Inc. | Li Ting | Director | Option Exercise | A | 2.75 | 10,897 | 29,967 | 10,897 | |
Nov 16 2018 | BSTG | Biostage, Inc. | Young Jeffrey E | Director | Option Exercise | A | 2.75 | 10,897 | 29,967 | 10,897 | |
Nov 15 2018 | BSTG | Biostage, Inc. | Chen Jing | Director | Option Exercise | A | 2.75 | 10,897 | 29,967 | 10,897 | |
Nov 15 2018 | BSTG | Biostage, Inc. | Zhang Wei | Director | Option Exercise | A | 2.75 | 10,897 | 29,967 | 10,897 | |
Nov 15 2018 | BSTG | Biostage, Inc. | Dallas Matthew D | Director | Option Exercise | A | 2.75 | 10,897 | 29,967 | 10,897 | |
Nov 15 2018 | BSTG | Biostage, Inc. | Shmerling James E. | Director | Option Exercise | A | 2.75 | 10,897 | 29,967 | 10,897 | |
Jul 16 2018 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Buy | P | 4.00 | 5,000 | 20,000 | 30,722 | 25.7 K to 30.7 K (+19.44 %) |
Jul 16 2018 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Buy | P | 4.00 | 5,000 | 20,000 | 30,722 | 25.7 K to 30.7 K (+19.44 %) |
Jul 06 2018 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Option Exercise | C | 2.00 | 3,000 | 6,000 | 0 | |
Jul 06 2018 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Buy | C | 0.00 | 1,500,000 | 0 | 2,000,000 | 500 K to 2 M (+300.00 %) |
Jul 06 2018 | BSTG | Biostage, Inc. | Chen Jing | Director | Option Exercise | C | 2.00 | 54 | 108 | 0 | |
Jul 06 2018 | BSTG | Biostage, Inc. | Chen Jing | Director | Buy | C | 0.00 | 27,000 | 0 | 36,000 | 9 K to 36 K (+300.00 %) |
Jul 03 2018 | BSTG | Biostage, Inc. | Du Xiaoyu | 10% Owner | Buy | P | 3.60 | 250,000 | 900,000 | 750,000 | 500 K to 750 K (+50.00 %) |
Jun 19 2018 | BSTG | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Buy | P | 4.40 | 2,500 | 11,000 | 13,734 | 11.2 K to 13.7 K (+22.25 %) |
Jun 18 2018 | BSTG | Biostage, Inc. | Yu Hong | President | Buy | P | 4.50 | 4,705 | 21,173 | 44,520 | 39.8 K to 44.5 K (+11.82 %) |
Jun 18 2018 | BSTG | Biostage, Inc. | Yu Hong | President | Buy | P | 4.39 | 14,645 | 64,292 | 39,815 | 25.2 K to 39.8 K (+58.18 %) |
Jun 14 2018 | BSTG | Biostage, Inc. | McGorry James Joseph | Chief Executive Off ... | Buy | P | 4.00 | 2,100 | 8,400 | 10,065 | 8 K to 10.1 K (+26.37 %) |
Jun 14 2018 | BSTG | Biostage, Inc. | Yu Hong | President | Buy | P | 3.75 | 650 | 2,438 | 25,170 | 24.5 K to 25.2 K (+2.65 %) |
Jun 14 2018 | BSTG | Biostage, Inc. | Yu Hong | President | Buy | P | 3.82 | 22,000 | 84,040 | 24,520 | 2.5 K to 24.5 K (+873.02 %) |
Jun 07 2018 | BSTG | Biostage, Inc. | Yu Hong | President | Option Exercise | A | 2.72 | 104,643 | 284,629 | 104,643 | |
Jun 07 2018 | BSTG | Biostage, Inc. | Yu Hong | President | Option Exercise | A | 2.72 | 104,643 | 284,629 | 104,643 | |
May 31 2018 | BSTG | Biostage, Inc. | McGorry James Joseph | Chief Executive Off ... | Option Exercise | A | 2.72 | 171,234 | 465,756 | 171,234 | |
May 31 2018 | BSTG | Biostage, Inc. | McGorry James Joseph | Chief Executive Off ... | Option Exercise | A | 2.72 | 171,233 | 465,754 | 171,233 | |
May 31 2018 | BSTG | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Option Exercise | A | 2.72 | 104,643 | 284,629 | 104,643 | |
May 31 2018 | BSTG | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Option Exercise | A | 2.72 | 104,643 | 284,629 | 104,643 | |
May 31 2018 | BSTG | Biostage, Inc. | Fodor William | Chief Scientific Of ... | Option Exercise | A | 2.72 | 104,643 | 284,629 | 104,643 | |
May 31 2018 | BSTG | Biostage, Inc. | Fodor William | Chief Scientific Of ... | Option Exercise | A | 2.72 | 104,643 | 284,629 | 104,643 | |
Mar 28 2018 | BSTG | Biostage, Inc. | McKee Blaine H. | Director | Option Exercise | M | 0.00 | 912 | 0 | 0 | |
Mar 28 2018 | BSTG | Biostage, Inc. | McKee Blaine H. | Director | Buy | M | 0.00 | 912 | 0 | 912 | 0 to 912 |
Mar 28 2018 | BSTG | Biostage, Inc. | Robinson Thomas H | Director | Option Exercise | M | 0.00 | 912 | 0 | 0 | |
Mar 28 2018 | BSTG | Biostage, Inc. | Robinson Thomas H | Director | Buy | M | 0.00 | 912 | 0 | 3,412 | 2.5 K to 3.4 K (+36.48 %) |
Mar 28 2018 | BSTG | Biostage, Inc. | McGorry James Joseph | Chief Executive Off ... | Option Exercise | M | 0.00 | 1,650 | 0 | 4,950 | |
Mar 28 2018 | BSTG | Biostage, Inc. | McGorry James Joseph | Chief Executive Off ... | Buy | M | 0.00 | 1,650 | 0 | 7,965 | 6.3 K to 8 K (+26.13 %) |
Mar 28 2018 | BSTG | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Option Exercise | M | 0.00 | 928 | 0 | 2,784 | |
Mar 28 2018 | BSTG | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Buy | M | 0.00 | 928 | 0 | 11,234 | 10.3 K to 11.2 K (+9.00 %) |
Mar 28 2018 | BSTG | Biostage, Inc. | Canepa John J | Director | Option Exercise | M | 0.00 | 912 | 0 | 0 | |
Mar 28 2018 | BSTG | Biostage, Inc. | Canepa John J | Director | Buy | M | 0.00 | 912 | 0 | 1,774 | 862 to 1.8 K (+105.80 %) |
Mar 02 2018 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Buy | P | 3.26 | 10,000 | 32,600 | 25,722 | 15.7 K to 25.7 K (+63.61 %) |
Jan 23 2018 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Buy | P | 2.67 | 1,572 | 4,197 | 15,722 | 14.2 K to 15.7 K (+11.11 %) |
Jan 22 2018 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Buy | P | 2.60 | 3,700 | 9,620 | 14,150 | 10.5 K to 14.2 K (+35.41 %) |
Jan 22 2018 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Buy | P | 2.20 | 5,000 | 11,000 | 10,450 | 5.5 K to 10.5 K (+91.74 %) |
Jan 16 2018 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Buy | P | 2.16 | 5,000 | 10,800 | 5,450 | 450 to 5.5 K (+1,111.11 %) |
Jan 16 2018 | BSTG | Biostage, Inc. | DST Capital LLC | 10% Owner | Buy | P | 1.90 | 200 | 380 | 450 | 250 to 450 (+80.00 %) |
Aug 25 2017 | BSTG | Biostage, Inc. | LaFrancesca Saverio | President and CMO | Buy | P | 0.37 | 100,000 | 37,000 | 293,998 | 194 K to 294 K (+51.55 %) |
Aug 24 2017 | BSTG | Biostage, Inc. | LaFrancesca Saverio | President and CMO | Buy | P | 0.32 | 150,000 | 48,000 | 193,998 | 44 K to 194 K (+340.92 %) |
Mar 16 2017 | HART | Biostage, Inc. | Robinson Thomas H | Director | Option Exercise | A | 0.00 | 18,250 | 0 | 18,250 | |
Mar 16 2017 | HART | Biostage, Inc. | Robinson Thomas H | Director | Option Exercise | A | 0.38 | 25,000 | 9,500 | 25,000 | |
Mar 16 2017 | HART | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Option Exercise | A | 0.00 | 74,250 | 0 | 74,250 | |
Mar 16 2017 | HART | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Option Exercise | A | 0.38 | 150,750 | 57,285 | 150,750 | |
Mar 16 2017 | HART | Biostage, Inc. | LaFrancesca Saverio | See Remarks | Option Exercise | A | 0.00 | 107,250 | 0 | 107,250 | |
Mar 16 2017 | HART | Biostage, Inc. | LaFrancesca Saverio | See Remarks | Option Exercise | A | 0.38 | 217,750 | 82,745 | 217,750 | |
Oct 14 2016 | HART | Biostage, Inc. | DerSimonian Harout | Chief Scientific Of ... | Buy | P | 0.91 | 10,000 | 9,100 | 10,000 | 0 to 10 K |
Aug 29 2016 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Buy | P | 0.93 | 16,182 | 15,033 | 58,406 | 42.2 K to 58.4 K (+38.32 %) |
Aug 25 2016 | HART | Biostage, Inc. | McGorry James Joseph | President and CEO | Buy | P | 0.96 | 25,000 | 24,000 | 126,300 | 101.3 K to 126.3 K (+24.68 %) |
Jun 22 2016 | HART | Biostage, Inc. | McGorry James Joseph | President and CEO | Buy | P | 1.07 | 20,000 | 21,400 | 101,300 | 81.3 K to 101.3 K (+24.60 %) |
Jun 14 2016 | HART | Biostage, Inc. | Robinson Thomas H | Director | Buy | P | 1.17 | 32,000 | 37,475 | 50,000 | 18 K to 50 K (+177.78 %) |
May 26 2016 | HART | Biostage, Inc. | Canepa John J | Director | Buy | P | 1.46 | 17,241 | 25,172 | 17,241 | 0 to 17.2 K |
May 23 2016 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Buy | P | 1.56 | 6,500 | 10,139 | 42,224 | 35.7 K to 42.2 K (+18.20 %) |
May 23 2016 | HART | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Buy | P | 1.55 | 2,500 | 3,875 | 206,128 | 203.6 K to 206.1 K (+1.23 %) |
May 23 2016 | HART | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Buy | P | 1.56 | 2,500 | 3,900 | 203,628 | 201.1 K to 203.6 K (+1.24 %) |
May 23 2016 | HART | Biostage, Inc. | McGorry James Joseph | President and CEO | Buy | P | 1.56 | 10,000 | 15,600 | 81,300 | 71.3 K to 81.3 K (+14.03 %) |
May 20 2016 | HART | Biostage, Inc. | Robinson Thomas H | Director | Buy | P | 1.36 | 18,000 | 24,401 | 18,000 | 0 to 18 K |
Mar 24 2016 | HART | Biostage, Inc. | Robinson Thomas H | Director | Option Exercise | A | 1.69 | 25,000 | 42,250 | 25,000 | |
Mar 24 2016 | HART | Biostage, Inc. | Canepa John J | Director | Option Exercise | A | 1.69 | 25,000 | 42,250 | 25,000 | |
Mar 24 2016 | HART | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Option Exercise | A | 1.69 | 75,000 | 126,750 | 75,000 | |
Mar 24 2016 | HART | Biostage, Inc. | McGorry James Joseph | President and CEO | Option Exercise | A | 1.69 | 150,000 | 253,500 | 150,000 | |
Mar 24 2016 | HART | Biostage, Inc. | LaFrancesca Saverio | Chief Medical Offic ... | Option Exercise | A | 1.69 | 75,000 | 126,750 | 75,000 | |
Mar 24 2016 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Option Exercise | A | 1.69 | 25,000 | 42,250 | 25,000 | |
Mar 24 2016 | HART | Biostage, Inc. | GREEN DAVID | Director | Option Exercise | A | 1.69 | 25,000 | 42,250 | 25,000 | |
Mar 24 2016 | HART | Biostage, Inc. | McKee Blaine H. | Director | Option Exercise | A | 1.69 | 25,000 | 42,250 | 25,000 | |
Mar 17 2016 | HART | Biostage, Inc. | McKee Blaine H. | Director | Option Exercise | A | 1.84 | 25,000 | 46,000 | 25,000 | |
Dec 18 2015 | HART | Biostage, Inc. | LaFrancesca Saverio | Chief Medical Offic ... | Buy | P | 2.01 | 2,393 | 4,817 | 43,998 | 41.6 K to 44 K (+5.75 %) |
Dec 18 2015 | HART | Biostage, Inc. | LaFrancesca Saverio | Chief Medical Offic ... | Sell | S | 1.93 | 2,393 | 4,615 | 41,605 | 44 K to 41.6 K (-5.44 %) |
Dec 01 2015 | HART | Biostage, Inc. | LaFrancesca Saverio | Chief Medical Offic ... | Buy | P | 3.01 | 10,000 | 30,052 | 43,998 | 34 K to 44 K (+29.41 %) |
Dec 01 2015 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Buy | P | 2.95 | 9,000 | 26,525 | 35,724 | 26.7 K to 35.7 K (+33.68 %) |
Nov 19 2015 | HART | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Buy | P | 1.70 | 10,000 | 17,000 | 201,128 | 191.1 K to 201.1 K (+5.23 %) |
Nov 19 2015 | HART | Biostage, Inc. | McGorry James Joseph | President and CEO | Buy | P | 1.79 | 10,000 | 17,900 | 71,300 | 61.3 K to 71.3 K (+16.31 %) |
Nov 18 2015 | HART | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Buy | P | 1.56 | 10,000 | 15,600 | 191,128 | 181.1 K to 191.1 K (+5.52 %) |
Nov 17 2015 | HART | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Buy | P | 1.32 | 15,000 | 19,800 | 181,128 | 166.1 K to 181.1 K (+9.03 %) |
Nov 17 2015 | HART | Biostage, Inc. | GREEN DAVID | Director | Buy | P | 1.34 | 25,000 | 33,500 | 313,259 | 288.3 K to 313.3 K (+8.67 %) |
Sep 21 2015 | HART | Biostage, Inc. | LaFrancesca Saverio | Chief Medical Offic ... | Buy | P | 1.28 | 4,500 | 5,760 | 33,998 | 29.5 K to 34 K (+15.26 %) |
Sep 21 2015 | HART | Biostage, Inc. | LaFrancesca Saverio | Chief Medical Offic ... | Buy | P | 1.29 | 5,000 | 6,450 | 29,498 | 24.5 K to 29.5 K (+20.41 %) |
Sep 18 2015 | HART | Biostage, Inc. | LaFrancesca Saverio | Chief Medical Offic ... | Buy | J | 1.22 | 10,284 | 12,546 | 21,998 | 11.7 K to 22 K (+87.79 %) |
Sep 01 2015 | HART | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Option Exercise | A | 1.40 | 100,000 | 140,000 | 100,000 | |
Sep 01 2015 | HART | Biostage, Inc. | LaFrancesca Saverio | Chief Medical Offic ... | Option Exercise | A | 1.40 | 160,000 | 224,000 | 160,000 | |
Sep 01 2015 | HART | Biostage, Inc. | LaFrancesca Saverio | Chief Medical Offic ... | Buy | P | 0.96 | 2,500 | 2,400 | 14,214 | 11.7 K to 14.2 K (+21.34 %) |
Aug 27 2015 | HART | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Buy | P | 0.88 | 10,000 | 8,800 | 166,128 | 156.1 K to 166.1 K (+6.41 %) |
Aug 24 2015 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Buy | P | 0.83 | 12,000 | 9,960 | 26,724 | 14.7 K to 26.7 K (+81.50 %) |
Aug 21 2015 | HART | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Buy | P | 0.76 | 25,000 | 19,000 | 156,128 | 131.1 K to 156.1 K (+19.07 %) |
Aug 21 2015 | HART | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Buy | P | 0.62 | 75,000 | 46,500 | 131,128 | 56.1 K to 131.1 K (+133.62 %) |
Aug 21 2015 | HART | Biostage, Inc. | McGorry James Joseph | President and CEO | Buy | P | 0.75 | 26,300 | 19,725 | 61,300 | 35 K to 61.3 K (+75.14 %) |
Aug 21 2015 | HART | Biostage, Inc. | McGorry James Joseph | President and CEO | Buy | P | 0.66 | 5,000 | 3,300 | 35,000 | 30 K to 35 K (+16.67 %) |
Jul 07 2015 | HART | Biostage, Inc. | McGorry James Joseph | President and CEO | Option Exercise | A | 1.38 | 671,400 | 926,532 | 671,400 | |
Jul 07 2015 | HART | Biostage, Inc. | McGorry James Joseph | President and CEO | Buy | P | 1.90 | 20,000 | 38,000 | 30,000 | 10 K to 30 K (+200.00 %) |
Jul 07 2015 | HART | Biostage, Inc. | McGorry James Joseph | President and CEO | Buy | P | 8.84 | 10,000 | 88,400 | 10,000 | 0 to 10 K |
Jun 08 2015 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Buy | P | 2.13 | 1,000 | 2,130 | 14,724 | 13.7 K to 14.7 K (+7.29 %) |